HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation
TSX-V:HME • CA4236301020
Current stock price
2.84 CAD
-0.02 (-0.7%)
Last:
This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HME.CA Profitability Analysis
1.1 Basic Checks
- HME had positive earnings in the past year.
- In the past year HME had a positive cash flow from operations.
- Each year in the past 5 years HME has been profitable.
- In the past 5 years HME always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 23.12%, HME belongs to the top of the industry, outperforming 98.03% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 34.75%, HME belongs to the top of the industry, outperforming 98.52% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 29.46%, HME belongs to the best of the industry, outperforming 99.01% of the companies in the same industry.
- HME had an Average Return On Invested Capital over the past 3 years of 32.46%. This is significantly above the industry average of 6.97%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROIC | 29.46% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
1.3 Margins
- HME has a Profit Margin of 29.84%. This is amongst the best in the industry. HME outperforms 94.58% of its industry peers.
- In the last couple of years the Profit Margin of HME has grown nicely.
- The Operating Margin of HME (42.20%) is better than 92.61% of its industry peers.
- In the last couple of years the Operating Margin of HME has grown nicely.
- HME's Gross Margin of 60.69% is fine compared to the rest of the industry. HME outperforms 77.83% of its industry peers.
- In the last couple of years the Gross Margin of HME has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% |
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
2. HME.CA Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
- The number of shares outstanding for HME has been reduced compared to 1 year ago.
- HME has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, HME has an improved debt to assets ratio.
2.2 Solvency
- HME has an Altman-Z score of 6.14. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
- HME has a better Altman-Z score (6.14) than 84.73% of its industry peers.
- The Debt to FCF ratio of HME is 0.09, which is an excellent value as it means it would take HME, only 0.09 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of HME (0.09) is better than 96.55% of its industry peers.
- A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
- HME's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. HME outperforms 76.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Altman-Z | 6.14 |
ROIC/WACC3.67
WACC8.03%
2.3 Liquidity
- HME has a Current Ratio of 1.37. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- HME has a better Current ratio (1.37) than 69.46% of its industry peers.
- A Quick Ratio of 1.37 indicates that HME should not have too much problems paying its short term obligations.
- HME's Quick ratio of 1.37 is fine compared to the rest of the industry. HME outperforms 70.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. HME.CA Growth Analysis
3.1 Past
- HME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.15%.
- The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
- HME shows a decrease in Revenue. In the last year, the revenue decreased by -6.07%.
- HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.14% yearly.
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
3.2 Future
- HME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -16.11% yearly.
- HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.33% yearly.
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. HME.CA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 10.14, which indicates a very decent valuation of HME.
- HME's Price/Earnings ratio is a bit cheaper when compared to the industry. HME is cheaper than 75.37% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.42, HME is valued rather cheaply.
- A Price/Forward Earnings ratio of 11.03 indicates a reasonable valuation of HME.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HME indicates a somewhat cheap valuation: HME is cheaper than 74.38% of the companies listed in the same industry.
- HME is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.14 | ||
| Fwd PE | 11.03 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HME is valued cheaply inside the industry as 90.64% of the companies are valued more expensively.
- HME's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HME is cheaper than 91.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.39 | ||
| EV/EBITDA | 4.91 |
4.3 Compensation for Growth
- HME has an outstanding profitability rating, which may justify a higher PE ratio.
- HME's earnings are expected to decrease with -16.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
5. HME.CA Dividend Analysis
5.1 Amount
- HME has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 3.03, HME pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.81, HME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- HME has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- 54.76% of the earnings are spent on dividend by HME. This is a bit on the high side, but may be sustainable.
DP54.76%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
HME.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:HME (4/24/2026, 7:00:00 PM)
2.84
-0.02 (-0.7%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-15 2026-04-15/bmo
Earnings (Next)05-20 2026-05-20
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners10.46%
Ins Owner ChangeN/A
Market Cap267.81M
Revenue(TTM)93.86M
Net Income(TTM)28.01M
Analysts84.44
Price Target2.96 (4.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP54.76%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14 2026-05-14 (0.03)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11%
Min EPS beat(2)-19.09%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-19.09%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.2%
EPS beat(12)4
Avg EPS beat(12)-3.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.09%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)-0.21%
Revenue beat(4)2
Avg Revenue beat(4)1.55%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)7
Avg Revenue beat(12)0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.03%
Revenue NY rev (1m)-3.26%
Revenue NY rev (3m)-7.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.14 | ||
| Fwd PE | 11.03 | ||
| P/S | 2.85 | ||
| P/FCF | 8.39 | ||
| P/OCF | 5.56 | ||
| P/B | 3.32 | ||
| P/tB | 3.32 | ||
| EV/EBITDA | 4.91 |
EPS(TTM)0.28
EY9.86%
EPS(NY)0.26
Fwd EY9.07%
FCF(TTM)0.34
FCFY11.91%
OCF(TTM)0.51
OCFY17.98%
SpS1
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.32039 (-18.3%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.12% | ||
| ROE | 34.75% | ||
| ROCE | 39.28% | ||
| ROIC | 29.46% | ||
| ROICexc | 36.52% | ||
| ROICexgc | 36.52% | ||
| OM | 42.2% | ||
| PM (TTM) | 29.84% | ||
| GM | 60.69% | ||
| FCFM | 33.99% |
ROA(3y)26.51%
ROA(5y)23.13%
ROE(3y)39.59%
ROE(5y)36.39%
ROIC(3y)32.46%
ROIC(5y)33.96%
ROICexc(3y)37.5%
ROICexc(5y)37.01%
ROICexgc(3y)37.5%
ROICexgc(5y)37.01%
ROCE(3y)43.29%
ROCE(5y)45.29%
ROICexgc growth 3Y-7.82%
ROICexgc growth 5Y43.82%
ROICexc growth 3Y-7.82%
ROICexc growth 5Y43.82%
OM growth 3Y-2.15%
OM growth 5Y14.92%
PM growth 3Y10.62%
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y1.06%
F-Score6
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.09 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 140.25% | ||
| Cap/Sales | 17.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.07% | ||
| Profit Quality | 113.94% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 6.14 |
F-Score6
WACC8.03%
ROIC/WACC3.67
Cap/Depr(3y)180.21%
Cap/Depr(5y)207.89%
Cap/Sales(3y)19.72%
Cap/Sales(5y)21.17%
Profit Quality(3y)100.55%
Profit Quality(5y)107.06%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.15%
EPS 3Y10.83%
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-8.04%
EPS Next 2Y-2.2%
EPS Next 3Y-16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.07%
Revenue growth 3Y-0.99%
Revenue growth 5Y38.14%
Sales Q2Q%-18.71%
Revenue Next Year-9.27%
Revenue Next 2Y-4.18%
Revenue Next 3Y-7.33%
Revenue Next 5YN/A
EBIT growth 1Y-11.49%
EBIT growth 3Y-3.12%
EBIT growth 5Y58.75%
EBIT Next Year28.61%
EBIT Next 3Y-3.62%
EBIT Next 5YN/A
FCF growth 1Y29.21%
FCF growth 3Y5.96%
FCF growth 5Y32.87%
OCF growth 1Y3.47%
OCF growth 3Y2.22%
OCF growth 5Y38.68%
HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
What is the profitability of HME stock?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
Can you provide the financial health for HME stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
What is the earnings growth outlook for HEMISPHERE ENERGY CORP?
The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -8.04% in the next year.